Authors:
Metzler, B
Anderton, SM
Manickasingham, SP
Wraith, DC
Citation: B. Metzler et al., Kinetics of peptide uptake and tissue distribution following a single intranasal dose of peptide, IMMUNOL INV, 29(1), 2000, pp. 61-70
Citation: B. Metzler et al., Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo, INT IMMUNOL, 11(5), 1999, pp. 667-675
Authors:
Burkhart, C
Liu, GY
Anderton, SM
Metzler, B
Wraith, DC
Citation: C. Burkhart et al., Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10, INT IMMUNOL, 11(10), 1999, pp. 1625-1634
Authors:
Lang, AK
Macht, LM
Kirwan, JR
Wraith, DC
Elson, CJ
Citation: Ak. Lang et al., Ability of T cells from patients with rheumatoid arthritis to respond to immunoglobulin G, IMMUNOLOGY, 98(1), 1999, pp. 116-122
Citation: B. Metzler et Dc. Wraith, Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functions, IMMUNOLOGY, 97(2), 1999, pp. 257-263
Citation: Cr. Shen et al., Splenic but not thymic autoreactive T cells from New Zealand Black mice respond to a dominant erythrocyte Band 3 peptide, IMMUNOLOGY, 96(4), 1999, pp. 595-599
Authors:
Anderton, SM
Kissler, S
Lamont, AG
Wraith, DC
Citation: Sm. Anderton et al., Therapeutic potential of TCR antagonists is determined by their ability tomodulate a diverse repertoire of autoreactive T cells, EUR J IMMUN, 29(6), 1999, pp. 1850-1857
Citation: C. Burkhart et al., Modulation of cytokine production following intranasal administration of antigenic peptide, TRANSPLAN P, 30(8), 1998, pp. 4186-4187